- Indexed in: Clarivate Analytics: Emerging Sources Citation Index (ESCI), and PubMed Central (PMC)
- Published at SAGE since 2018
- Publication is subject to payment of an article processing charge (APC)
Allergy & Rhinology is an open access, peer reviewed international journal covering all areas of research from surgical techniques to diagnostic dilemmas, as well as treatment options and pathophysiologic investigations in sinonasal diseases, as well as asthma and other allergic disorders. Please see the Aims and Scope tab for further information.
This journal is a member of the Committee on Publication Ethics (COPE).
Submit your manuscript at https://mc.manuscriptcentral.com/allergyandrhinology.
Please see the Submission Guidelines tab for more information on how to submit your article to the journal.
Open access article processing charge (APC) information
Publication in the journal is subject to payment of an article processing charge (APC). The APC serves to support the journal and ensures that articles are freely accessible online in perpetuity under a Creative Commons license.
The APC for this journal is currently $750 USD.
The article processing charge (APC) is payable only if your article is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Tax-exempt status can be indicated by providing appropriate registration numbers when payment is requested. Please see further details here.
Please direct any queries to Kiley Allen, Associate Publishing Editor. Kiley.email@example.com
Allergy & Rhinology is a leading, open access, peer reviewed, medical specialty journal in press since 2010. Its aim is to provide a platform for original research, clinical trials, review articles and case reports within an Open Access platform. Allergy & Rhinology publishes articles ranging in topics from surgical techniques to diagnostic dilemmas, as well as treatment options and pathophysiologic investigations in sinonasal diseases, asthma and other allergic disorders.
|Russell Settipane, MD||Alpert Medical School of Brown University, Providence, RI, USA|
|Miguel Armengot, MD||University and Politechnic Hospital le Fe, Valencia, Spain|
|J. A. Bellanti||Georgetown University, USA|
|Yuriy Bisyuk, MD, PhD||Shupyk National Medical Academy of Postgraduate Education, Ukraine|
|Mehmet Bostanciklioglu||Gaziantep University, Turkey|
|Rakesh Chandra, MD||Vanderbilt University, Nashville, TN, USA|
|David Charnock, MD||University of Vermont, Burlington, VT, USA|
|Alex Chiu, MD||University of Kansas Medical Center, Kansas City, Kansas, USA|
|Lawrence M. DuBuske, MD||George Washington University, Washington, DC, USA|
|John M. Fahrenholz, MD||Vanderbilt University Medical Center, Nashville, TN, USA|
|Andrew Foreman, MD||University of Adelaide, Kent Town, SA, Australia|
|Kyung-Su Kim, MD||Yonsei University College of Medicine, Seoul, South Korea|
|Wei-Jia Kong, MD||Huazhong University of Science & Technology, Wuhan, China|
|Alton Melton, MD||Cleveland Clinic, Cleveland, OH, USA|
|Paul T. Russell, MD||Vanderbilt University Medical Center, Nashville, TN, USA|
|Dareen Siri, MD||Southern Illinois University, Springfield, IL, USA|
|Justin Turner, MD||Vanderbilt University Medical Center, Nashville, TN, USA|
|Wahidah Wahid, MBBS MRCS(ENT)||Southend University Hospital NHS Foundation Trust, Essex, United Kingdom|
This Journal is a member of the Committee on Publication Ethics.
This Journal recommends that authors follow the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).
Please read the guidelines below then visit the journal’s submission site to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned.
Only manuscripts of sufficient quality that meet the aims and scope of Allergy & Rhinology will be reviewed.
As part of the submission process you will be required to warrant that you are submitting your original work, that you have the rights in the work, that you are submitting the work for first publication in the Journal and that it is not being considered for publication elsewhere and has not already been published elsewhere, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you.
Please Read the Manuscript Submission Guidelines below before submitting your manuscript here:
- Open Access
- Article processing charge (APC)
- What do we publish?
3.1 Aims & scope
3.2 Article types
3.3 Writing your paper
3.3.1 Making your article discoverable
- Editorial policies
4.1 Peer Review Policy
4.5 Declaration of conflicting interests
4.6 Research ethics and patient consent
4.7 Clinical Trials
4.8 Reporting guidelines
- Publishing policies
5.1 Publication ethics
5.2 Contributor's publishing agreement
- Preparing your manuscript
6.1 Word processing formats
6.2 Artwork, figures and other graphics
6.3 Supplemental material
6.4 Reference style
6.5 English language editing services
- Submitting your manuscript
7.1 How to submit your manuscript
7.2 Title, keywords and abstracts
7.3 Information required for completing your submission
7.5 Information required for completing your submission
- On acceptance and publication
8.1 SAGE Production
8.2 Continuous publication
8.3 Promoting your article
- Further information
Allergy & Rhinology is an open access, peer-reviewed journal. Each article accepted by peer review is
made freely available online immediately upon publication, is published under a Creative Commons
license and will be hosted online in perpetuity. Publication costs of the journal are covered by the
collection of article processing charges which are paid by the funder, institution or author of each
manuscript upon acceptance. There is no charge for submitting a paper to the journal.
If, after peer review, your manuscript is accepted for publication, a one-time article processing charge
(APC) is payable. This APC covers the cost of publication and ensures that your article will be freely
available online in perpetuity under a Creative Commons license.
The article processing charge (APC) is $750 USD.
*If the paying party is based in the European Union, to comply with European law, value added tax (VAT)
must be added to the APC. Providing a VAT registration number will allow an institution to be exempt
from paying this tax, except for UK institutions.
Before submitting your manuscript to Allergy & Rhinology, please ensure you have read the
Aims & Scope.
- Original manuscript: Provides the results of original laboratory and/or clinical research.
Components indicated by a checkmark below should appear in the order they are presented
here (ie. title page, abstract, manuscript text, acknowledgment, references, figure legends,
tables, figures). Word Limit: 2500 words (exceptions allowed under special circumstances)
- Review: Manuscript that provides a review of previously published literature. Components
indicated by a checkmark below should appear in the order they are presented here (ie. title
page, abstract, manuscript text, acknowledgment, references, figure legends, tables, figures)
Word limit: 3000 words
- Clinical Trial
- Letters to the Editor: A letter to the Editor is a brief communication that either addresses the
contents of a published article, or is a correspondence unrelated to a specific article. Its
purpose is to make corrections, provide alternative viewpoints, or offer counter arguments.
Avoid logical fallacies and ad hominem attacks. Letters to the Editor must be written in a
professional tone and include references to support all claims if appropriate. A letter to the
Editor unrelated to a specific article should not exceed 500 words or have more than 3
references. A letter to the Editor pertaining to a recently published article or to be published
concurrently with an article within the journal should not exceed 800 words or have more than
5 references. If an abstract is included, it will automatically be made the first paragraph. Letters
should not include figures or research material. Letters to the editor are not charged an APC.
- Case Reports: Allergy & Rhinology will review case reports that are truly unique and have an
exceptional teaching value.
The SAGE Author Gateway has some general advice and on how to get published, plus links to
When writing up your paper, think about how you can make it discoverable. The title,
keywords and abstract are key to ensuring readers find your article through search
engines such as Google. For information and guidance on how best to title your article,
write your abstract and select your keywords, have a look at this page on the Gateway:
How to Help Readers Find Your Article Online
The journal’s policy is to have manuscripts reviewed by two expert reviewers. Allergy &
Rhinology utilizes a single-blind peer review process in which the reviewer’s name and
information is withheld from the author. All manuscripts are reviewed as rapidly as possible,
while maintaining rigor. Reviewers make comments to the author and recommendations to the
Editor-in-Chief who then makes the final decision.
FOR JOURNALS USING RECOMMENDED/OPPOSED REVIEWERS
As part of the submission process you will be asked to provide the names of [X #] peers who
could be called upon to review your manuscript. Recommended reviewers should be experts in
their fields and should be able to provide an objective assessment of the manuscript. Please be
aware of any conflicts of interest when recommending reviewers. Examples of conflicts of
interest include (but are not limited to) the below:
• The reviewer should have no prior knowledge of your submission
• The reviewer should not have recently collaborated with any of the authors
• Reviewer nominees from the same institution as any of the authors are not permitted
You will also be asked to nominate peers who you do not wish to review your manuscript
Please note that the Editors are not obliged to invite any recommended/opposed reviewers to
assess your manuscript.
The Editor or members of the Editorial Board may occasionally submit their own manuscripts for
possible publication in the journal. In these cases, the peer review process will be managed by
alternative members of the Board and the submitting Editor / Board member will have no
involvement in the decision-making process.
Allergy & Rhinology is committed to delivering high quality, fast peer-review for your paper, and
as such has partnered with Publons. Publons is a third party service that seeks to track, verify
and give credit for peer review. Reviewers for Allergy & Rhinology can opt in to Publons in order
to claim their reviews or have them automatically verified and added to their reviewer profile.
Reviewers claiming credit for their review will be associated with the relevant journal, but the
article name, reviewer’s decision and the content of their review is not published on the site.
For more information visit the Publons website.
Papers should only be submitted for consideration once consent is given by all contributing
authors. Those submitting papers should carefully check that all those whose work contributed
to the paper are acknowledged as contributing authors.
The list of authors should include all those who can legitimately claim authorship. This is all
(i) Made a substantial contribution to the concept or design of the work; or acquisition,
analysis or interpretation of data,
(ii) Drafted the article or revised it critically for important intellectual content,
(iii) Approved the version to be published
Authors should meet the conditions of all of the points above. Each author should have
participated sufficiently in the work to take public responsibility for appropriate portions of the
When a large, multicentre group has conducted the work, the group should identify the
individuals who accept direct responsibility for the manuscript. These individuals should fully
meet the criteria for authorship.
Acquisition of funding, collection of data, or general supervision of the research group alone
does not constitute authorship, although all contributors who do not meet the criteria for
authorship should be listed in the Acknowledgments section. Please refer to the International
Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information on
All contributors who do not meet the criteria for authorship should be listed in an
Acknowledgements section. Examples of those who might be acknowledged include a person
who provided purely technical help, or a department chair who provided only general support.
4.3.1 Writing assistance
Individuals who provided writing assistance, e.g. from a specialist communications company, do
not qualify as authors and so should be included in the Acknowledgements section. Authors
must disclose any writing assistance – including the individual’s name, company and level of
input – and identify the entity that paid for this assistance.
It is not necessary to disclose use of language polishing services.
Any acknowledgements should appear first at the end of your article prior to your Declaration of
Conflicting Interests (if applicable), any notes and your References.
Allergy & Rhinology requires all authors to acknowledge their funding in a consistent fashion
under a separate heading. Please visit the Funding Acknowledgements page on the SAGE
Journal Author Gateway to confirm the format of the acknowledgment text in the event of
funding, or state that: This research received no specific grant from any funding agency in the
public, commercial, or not-for-profit sectors.
It is the policy of Allergy & Rhinology to require a declaration of conflicting interests from all
authors enabling a statement to be carried within the paginated pages of all published articles.
Please ensure that a ‘Declaration of Conflicting Interests’ statement is included at the end of
your manuscript, after any acknowledgements and prior to the references. If no conflict exists,
please state that ‘The Author(s) declare(s) that there is no conflict of interest’.
For guidance on conflict of interest statements, please see the ICMJE recommendations.
Medical research involving human subjects must be conducted according to the World Medical
Association Declaration of Helsinki.
Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct,
Reporting, Editing, and Publication of Scholarly Work in Medical Journals, and all papers
reporting animal and/or human studies must state in the methods section that the relevant
Ethics Committee or Institutional Review Board provided (or waived) approval. Please ensure
that you have provided the full name and institution of the review committee, in addition to the
For research articles, authors are also required to state in the methods section whether
participants provided informed consent and whether the consent was written or verbal.
Information on informed consent to report individual cases or case series should be included in
the manuscript text. A statement is required regarding whether written informed consent for
patient information and images to be published was provided by the patient(s) or a legally
authorized representative. Please do not submit the patient’s actual written informed consent with
your article, as this in itself breaches the patient’s confidentiality. The Journal requests that you
confirm to us, in writing, that you have obtained written informed consent but the written consent
itself should be held by the authors/investigators themselves, for example in a patient’s hospital
record. The confirmatory letter may be uploaded with your submission as a separate file.
Please also refer to the ICMJE Recommendations for the Protection of Research Participants
All research involving animals submitted for publication must be approved by an ethics
committee with oversight of the facility in which the studies were conducted. The journal has
adopted the Consensus Author Guidelines on Animal Ethics and Welfare for Veterinary Journals
published by the International Association of Veterinary Editors.
Allergy & Rhinology conforms to the ICMJE requirement that clinical trials are registered in a
WHO-approved public trials registry at or before the time of first patient enrolment as a
condition of consideration for publication. The trial registry name and URL, and registration
number must be included at the end of the abstract.
The relevant EQUATOR Network reporting guidelines should be followed depending on the type
of study. For example, all randomized controlled trials submitted for publication should include
a completed CONSORT flow chart as a cited figure and the completed CONSORT checklist should
be uploaded with your submission as a supplementary file. Systematic reviews and metaanalyses
should include the completed PRISMA flow chart as a cited figure and the completed
PRISMA checklist should be uploaded with your submission as a supplementary file. The
EQUATOR wizard can help you identify the appropriate guideline.
Other resources can be found at NLM’s Research Reporting Guidelines and Initiatives.
4.9 Research Data
At SAGE we are committed to facilitating openness, transparency and reproducibility of research.
Where relevant, Allergy & Rhinology encourages authors to share their research data in a suitable public
repository subject to ethical considerations and to include a data accessibility statement in their
manuscript file. Authors should also follow data citation principles. For more information please visit
the SAGE Author Gateway, which includes information about SAGE’s partnership with the data
SAGE is committed to upholding the integrity of the academic record. We encourage authors to
refer to the Committee on Publication Ethics’ International Standards for Authors and view the
Publication Ethics page on the SAGE Author Gateway.
Allergy & Rhinology and SAGE take issues of copyright infringement, plagiarism or other
breaches of best practice in publication very seriously. We seek to protect the rights of our
authors and we always investigate claims of plagiarism or misuse of published articles. Equally,
we seek to protect the reputation of the journal against malpractice. Submitted articles may be
checked with duplication-checking software. Where an article, for example, is found to have
plagiarized other work or included third-party copyright material without permission or with
insufficient acknowledgement, or where the authorship of the article is contested, we reserve
the right to take action including, but not limited to: publishing an erratum or corrigendum
(correction); retracting the article; taking up the matter with the head of department or dean of
the author's institution and/or relevant academic bodies or societies; or taking appropriate legal
5.1.2 Prior publication
If material has been previously published, it is not generally acceptable for publication in a SAGE
journal. However, there are certain circumstances where previously published material can be
considered for publication. Please refer to the guidance on the SAGE Author Gateway or if in
doubt, contact the Editor at the address given below.
Before publication SAGE requires the author as the rights holder to sign a Journal Contributor’s
Publishing Agreement. Allergy & Rhinology publishes manuscripts under Creative Commons
licenses. The standard license for the journal is Creative Commons by Attribution NonCommercial
(CC BY-NC), which allows others to re-use the work without permission as long as
the work is properly referenced and the use is non-commercial. For more information, you are
advised to visit SAGE's OA licenses page.
Alternative license arrangements are available, for example, to meet particular funder
mandates, made at the author’s request.
The preferred format for your manuscript is Word. LaTeX files are also accepted. Word and
(La)Tex templates are available on the Manuscript Submission Guidelines page of our Author
For guidance on the preparation of illustrations, pictures and graphs in electronic format, please
visit SAGE’s Manuscript Submission Guidelines
Figures supplied in color will appear in color online.
This journal is able to host additional materials online (e.g. datasets, podcasts, videos, images
etc) alongside the full-text of the article. These will be subjected to peer-review alongside the
article. For more information please refer to our guidelines on submitting supplementary files,
which can be found within our Manuscript Submission Guidelines page.
Allergy & Rhinology adheres to the AMA (American Medical Association) reference style. Please
review the guidelines on AMA style to ensure your manuscript conforms to this reference style. We have also linked to the AMA Output File.
Authors seeking assistance with English language editing, translation, or figure and manuscript
formatting to fit the journal’s specifications should consider using SAGE Language Services. Visit
SAGE Language Services on our Journal Author Gateway for further information.
Allergy & Rhinology is hosted on SAGE Track, a web based online submission and peer review
system powered by ScholarOne™ Manuscripts. Visit the journal’s submission site to login and
submit your article online.
IMPORTANT: Please check whether you already have an account in the system before trying to
create a new one. If you have reviewed or authored for the journal in the past year it is likely
that you will have had an account created. For further guidance on submitting your manuscript
online please visit ScholarOne Online Help.
Please supply a title, short title, an abstract and keywords to accompany your article. The title,
keywords and abstract are key to ensuring readers find your article online through online search
engines such as Google. Please refer to the information and guidance on how best to title your
article, write your abstract and select your keywords by visiting the SAGE Journal Author
Gateway for guidelines on How to Help Readers Find Your Article Online.
Provide full contact details for the corresponding author including email, mailing address and
telephone numbers. Academic affiliations are required for all co-authors. These details should
be presented separately to the main text of the article to facilitate anonymous peer review.
You will be asked to provide contact details and academic affiliations for all co-authors via the
submission system and identify who is to be the corresponding author. These details must
match what appears on your manuscript. At this stage please ensure you have included all the
required statements and declarations and uploaded any additional supplementary files
(including reporting guidelines where relevant).
As part of our commitment to ensuring an ethical, transparent and fair peer review process SAGE
is a supporting member of ORCID, the Open Researcher and Contributor ID. ORCID provides a
unique and persistent digital identifier that distinguishes researchers from every other researcher,
even those who share the same name, and, through integration in key research workflows such as
manuscript and grant submission, supports automated linkages between researchers and their
professional activities, ensuring that their work is recognized.
The collection of ORCID iDs from corresponding authors is now part of the submission process of
this journal. If you already have an ORCID iD you will be asked to associate that to your submission
during the online submission process. We also strongly encourage all co-authors to link their ORCID
ID to their accounts in our online peer review platforms. It takes seconds to do: click the link when
prompted, sign into your ORCID account and our systems are automatically updated. Your ORCID
iD will become part of your accepted publication’s metadata, making your work attributable to you
and only you. Your ORCID iD is published with your article so that fellow researchers reading your
work can link to your ORCID profile and from there link to your other publications.
You will be asked to provide contact details and academic affiliations for all co-authors via the
submission system and identify who is to be the corresponding author. These details must match what
appears on your manuscript. The affiliation listed on the manuscript should be the institution where
the research was conducted. If an author has moved to a new institution since completing the research,
the new affiliation can be included in a manuscript note at the end of the paper. At this stage please
ensure you have included all the required statements and declarations and uploaded any additional
supplementary files (including reporting guidelines where relevant).
Please ensure that you have obtained any necessary permission from copyright holders for reproducing
any illustrations, tables, figures or lengthy quotations previously published elsewhere. For further
information including guidance on fair dealing for criticism and review, please see the Copyright and
Permissions page on the SAGE Journal Author Gateway.
If your paper is accepted for publication after peer review, you will first be asked to complete the
contributor’s publishing agreement. Once your manuscript files have been checked for SAGE Production,
the corresponding author will be asked to pay the article processing charge (APC) via a payment link.
Once the APC has been processed, your article will be prepared for publication and can appear online
within an average of 30 days. Please note that no production work will occur on your paper until the
APC has been received.
Your SAGE Production Editor will keep you informed as to your article’s progress throughout the
production process. Proofs will made available to the corresponding author via our editing portal SAGE
Edit, or by email to the corresponding author and should be returned promptly. Authors are reminded
to check their proofs carefully to confirm that all author information, including names, affiliations,
sequence and contact details are correct, and that Funding and Conflict of Interest statements, if any,
are accurate. Please note that if there are any changes to the author list at this stage all authors will be
required to complete and sign a form authorizing the change.
One of the many benefits of publishing your research in an open access journal is the speed to
publication. With no page count constraints, your article will be published online in a fully
citable form with a DOI number as soon as it has completed the production process. At this time
it will be completely free to view and download for all.
Publication is not the end of the process! You can help disseminate your paper and ensure it is
as widely read and cited as possible. The SAGE Author Gateway has numerous resources to help
you promote your work. Visit the Promote Your Article page on the Gateway for tips and advice.
In addition, SAGE is partnered with Kudos, a free service that allows authors to explain, enrich,
share, and measure the impact of their article. Find out how to maximize your article’s impact
Any correspondence, queries or additional requests for information on the Manuscript Submission
process should be sent to the Allergy & Rhinology editorial office as follows: